Learn More
BACKGROUND The recommended strategy for elimination of Lymphatic filariasis is single-dose, once-yearly mass treatment with anti-filarial drugs and the program is in operation on a national level in India. Rate of coverage and consumption is the most crucial factor in the success of Mass Drug Administration (MDA) program. In spite of massive efforts, the(More)
OBJECTIVE To estimate the burden of chikungunya in terms of financial and opportunity costs through a cross sectional survey from an affected area in Tamil Nadu. METHODS A survey of 809 households with a population of 4393 showed 59 individuals suffered from clinical symptoms of chikungunya. Using pre-tested questionnaire, information on the source of(More)
Community compliance is crucial for the success of mass treatment using cooking salt fortified with diethylcarbamazine citrate (DEC) for the elimination of lymphatic filariasis (LF). We describe the role and effectiveness of school-based health education for social mobilization to promote the use of DEC salt, in an endemic district in India. Health(More)
Globally mosquito-borne lymphatic filariasis (LF) is targeted for elimination by 2020. Towards this goal, the scope of community-based vector control as a supplementary strategy to mass drug administration (MDA) was assessed through an intensive education campaign and evaluated using pre- and post-educational surveys in an intervention and comparison(More)
India is a signatory to World Health Assembly resolution for elimination of lymphatic filariasis (LF) and National Health Policy has set the goal of LF elimination by 2015. Annual mass drug administration (MDA) is ongoing in endemic districts since 1996-97. Compliance rate is a crucial factor in achieving elimination and was assessed in three districts of(More)
Cutaneous leishmaniasis (CL) is reported among Kani tribes in forest settlements of Tiruvananthapuram district, Kerala, India. Epidemiological investigations are ongoing and 27 histopathologically confirmed cases of CL have been reported from five settlements indicating transmission of disease within settlements. One of the priorities for control/prevention(More)
Diethylcarbamazinecitrate (DEC) salt in conjunction with annual single-dose mass drug administration (MDA) with DEC tablets can be considered as potential option to hasten the process of Lymphatic Filariasis (LF) elimination. Consumption of DEC tablet/salt by at least 80% of the endemic population is crucial in achieving elimination in five years. This(More)
  • 1